Renal Cancer - Results from #2020

Comparison of Perioperative Outcomes for Radical Nephrectomy Based on Surgical Approach for Masses Greater than 10cm. June 28, 2021

Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics. June 25, 2021

Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System. June 25, 2021

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden. June 24, 2021

Surgery for renal cell carcinoma extending to the right atrium in Japanese institutions: Focusing on cardiopulmonary bypass with or without deep hypothermic circulatory arrest. June 24, 2021

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study. June 23, 2021

Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017. June 23, 2021

Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis. June 23, 2021

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy. June 22, 2021

Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. June 22, 2021

Comparison of Different Machine Models Based on Contrast-Enhanced Computed Tomography Radiomic Features to Differentiate High From Low Grade Clear Cell Renal Cell Carcinomas. June 21, 2021

Race/ethnicity and advanced stage of renal cell carcinoma in adults: results from surveillance, epidemiology, and end results program 2007-2015. June 21, 2021

Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. June 18, 2021

Active surveillance in renal tumors: Clinical and oncological outcomes. June 18, 2021

Germline Variants in Renal Cell Carcinoma Patients - Expert Commentary June 17, 2021

Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes from the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort. June 17, 2021

Differential effect of body mass index by gender on oncological outcomes in patients with renal cell carcinoma. June 17, 2021

Real-world Clinical Effectiveness of Lenvatinib/Everolimus in a Heavily Pretreated Advanced/Metastatic Renal Cell Carcinoma Population in the US Community Oncology Setting. June 16, 2021

Gene expression signature correlates with outcomes in metastatic renal cell carcinoma patients treated with everolimus alone or with a vascular disrupting agent. June 16, 2021

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. June 15, 2021

Page 102 of 458